BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24259979)

  • 1. Combined radiochemotherapy in patients with locally advanced pancreatic cancer: a meta-analysis.
    Chen Y; Sun XJ; Jiang TH; Mao AW
    World J Gastroenterol; 2013 Nov; 19(42):7461-71. PubMed ID: 24259979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
    Torgeson A; Lloyd S; Boothe D; Tao R; Whisenant J; Garrido-Laguna I; Cannon GM
    Cancer; 2017 Oct; 123(19):3816-3824. PubMed ID: 28621885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
    Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
    Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer.
    Zhong J; Switchenko J; Behera M; Kooby D; Maithel SK; McDonald MW; Lin JY; Cassidy RJ; El-Rayes B; Landry J; Patel PR
    Ann Surg Oncol; 2018 Apr; 25(4):1026-1033. PubMed ID: 29327180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head.
    Denost Q; Laurent C; Adam JP; Capdepont M; Vendrely V; Collet D; Cunha AS
    HPB (Oxford); 2013 Sep; 15(9):716-23. PubMed ID: 23458326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of radiation to chemotherapy does not improve outcome when compared to chemotherapy in the treatment of resected pancreas cancer: the results of a single-institution experience.
    Martin LK; Luu DC; Li X; Muscarella P; Ellison EC; Bloomston M; Bekaii-Saab T
    Ann Surg Oncol; 2014 Mar; 21(3):862-867. PubMed ID: 24046122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database.
    Amini A; Jones BL; Stumpf P; Leong S; Lieu CH; Weekes C; Davis SL; Messersmith WA; Purcell WT; Ghosh D; Schefter T; Goodman KA
    Pancreas; 2017 Aug; 46(7):904-912. PubMed ID: 28697131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of chemoradiotherapy in the management of locally advanced pancreatic adenocarcinoma: systematic review].
    Azria D; Seblain-El-Guerche C; Girard N; Hennequin C; Huguet F
    Bull Cancer; 2008 Nov; 95(11):1116-30. PubMed ID: 19036684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.
    Choi Y; Oh DY; Kim K; Chie EK; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Ha SW; Bang YJ
    Cancer Res Treat; 2016 Jul; 48(3):1045-55. PubMed ID: 26511805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Overall Survival Between Preoperative Chemotherapy and Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma.
    Mokdad AA; Minter RM; Yopp AC; Porembka MR; Wang SC; Zhu H; Augustine MM; Mansour JC; Choti MA; Polanco PM
    J Natl Compr Canc Netw; 2018 Dec; 16(12):1468-1475. PubMed ID: 30545994
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
    J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial.
    Maluta S; Schaffer M; Pioli F; Dall'oglio S; Pasetto S; Schaffer PM; Weber B; Giri MG
    Strahlenther Onkol; 2011 Oct; 187(10):619-25. PubMed ID: 21932025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
    Jingjing H; Rui J; Hui P
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
    Herman JM; Swartz MJ; Hsu CC; Winter J; Pawlik TM; Sugar E; Robinson R; Laheru DA; Jaffee E; Hruban RH; Campbell KA; Wolfgang CL; Asrari F; Donehower R; Hidalgo M; Diaz LA; Yeo C; Cameron JL; Schulick RD; Abrams R
    J Clin Oncol; 2008 Jul; 26(21):3503-10. PubMed ID: 18640931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection and radiochemotherapy of pancreatic cancer--the future?
    Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
    Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer.
    Yang SH; Guo JC; Yeh KH; Tien YW; Cheng AL; Kuo SH
    J Gastroenterol Hepatol; 2016 Dec; 31(12):2004-2012. PubMed ID: 27059987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review.
    Liu W; Fu XL; Yang JY; Liu DJ; Li J; Zhang JF; Huo YM; Yang MW; Hua R; Sun YW
    Medicine (Baltimore); 2016 Apr; 95(15):e3009. PubMed ID: 27082545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1).
    Arcelli A; Buwenge M; Macchia G; Bertini F; Guido A; Deodato F; Cilla S; Scotti V; Rosetto ME; Djan I; Parisi S; Mattiucci GC; Cellini F; Fiore M; Bonomo P; Belgioia L; Niespolo RM; Gabriele P; Di Marco M; Simoni N; Mazzarotto R; Morganti AG;
    Cancer Med; 2020 Nov; 9(21):7879-7887. PubMed ID: 32910549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
    Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
    Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer.
    Watanabe T; Ueno H; Watabe Y; Hiraoka N; Morizane C; Itami J; Okusaka T; Miura N; Kakizaki T; Kakuya T; Kamita M; Tsuchida A; Nagakawa Y; Wilber H; Yamada T; Honda K
    Br J Cancer; 2015 Feb; 112(4):704-13. PubMed ID: 25602965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.